Nagao M - Search Results

1

Potential Utility of Circulating MicroRNA-483 as a Biomarker for IGF-II-Associated Non-Islet Cell Tumor Hypoglycemia.

Okazaki-Hada M, Nagao M, Asai A, Okada-Iwabu M, Hizuka N, Eliasson L, Sugihara H, Fukuda I, Iwabu M. Okazaki-Hada M, et al. Among authors: nagao m. J Clin Endocrinol Metab. 2024 Dec 17:dgae879. doi: 10.1210/clinem/dgae879. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39689018

2

Diagnostic potential of miR-483 family for IGF-II producing non-islet cell tumor hypoglycemia.

Nagao M, Fukuda I, Asai A, Esguerra JLS, Hizuka N, Eliasson L, Sugihara H. Nagao M, et al. Eur J Endocrinol. 2021 Jan;184(1):41-49. doi: 10.1530/EJE-20-0706. Eur J Endocrinol. 2021. PMID: 33112286

3

MicroRNAs in islet hormone secretion.

Esguerra JLS, Nagao M, Ofori JK, Wendt A, Eliasson L. Esguerra JLS, et al. Among authors: nagao m. Diabetes Obes Metab. 2018 Sep;20 Suppl 2:11-19. doi: 10.1111/dom.13382. Diabetes Obes Metab. 2018. PMID: 30230181 Review.

4

Multiple daily insulin injections ameliorate QT interval by lowering blood glucose levels in patients with type 2 diabetes.

Kobayashi S, Nagao M, Fukuda I, Oikawa S, Sugihara H. Kobayashi S, et al. Among authors: nagao m. Ther Adv Endocrinol Metab. 2021 Apr 22;12:20420188211010057. doi: 10.1177/20420188211010057. eCollection 2021. Ther Adv Endocrinol Metab. 2021. PMID: 34104393 Free PMC article.

5

Perioperative glycemic status is linked to postoperative complications in non-intensive care unit patients with type-2 diabetes: a retrospective study.

Oba T, Nagao M, Kobayashi S, Yamaguchi Y, Nagamine T, Tanimura-Inagaki K, Fukuda I, Sugihara H. Oba T, et al. Among authors: nagao m. Ther Adv Endocrinol Metab. 2022 May 19;13:20420188221099349. doi: 10.1177/20420188221099349. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 35646304 Free PMC article.

6

A case of pheochromocytoma associated with liver abscess and intestinal pseudo-obstruction.

Okazaki-Hada M, Fukuda I, Nagaoka R, Nagao M, Igarashi T, Kobayashi S, Oba T, Yamaguchi Y, Nagamine T, Sugitani I, Sugihara H. Okazaki-Hada M, et al. Among authors: nagao m. Ther Adv Endocrinol Metab. 2022 Dec 10;13:20420188221139652. doi: 10.1177/20420188221139652. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 36533183 Free PMC article.

7

HLA investigation in ICI-induced T1D and isolated ACTH deficiency including meta-analysis.

Ono M, Nagao M, Takeuchi H, Fukunaga E, Nagamine T, Inagaki K, Fukuda I, Iwabu M. Ono M, et al. Among authors: nagao m. Eur J Endocrinol. 2024 Jul 2;191(1):9-16. doi: 10.1093/ejendo/lvae081. Eur J Endocrinol. 2024. PMID: 38917237

8

Fat intake and the development of type 2 diabetes.

Nagao M, Asai A, Sugihara H, Oikawa S. Nagao M, et al. Endocr J. 2015;62(7):561-72. doi: 10.1507/endocrj.EJ15-0055. Epub 2015 May 28. Endocr J. 2015. PMID: 25924665 Free article. Review.

9

Glucocorticoid induces human beta cell dysfunction by involving riborepressor GAS5 LincRNA.

Esguerra JLS, Ofori JK, Nagao M, Shuto Y, Karagiannopoulos A, Fadista J, Sugihara H, Groop L, Eliasson L. Esguerra JLS, et al. Among authors: nagao m. Mol Metab. 2020 Feb;32:160-167. doi: 10.1016/j.molmet.2019.12.012. Epub 2019 Dec 27. Mol Metab. 2020. PMID: 32029226 Free PMC article.

10

Potential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in β-Cells.

Nagao M, Esguerra JLS, Asai A, Ofori JK, Edlund A, Wendt A, Sugihara H, Wollheim CB, Oikawa S, Eliasson L. Nagao M, et al. Diabetes. 2020 Jun;69(6):1193-1205. doi: 10.2337/db19-0944. Epub 2020 Mar 20. Diabetes. 2020. PMID: 32198214 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,083 results

Search Page

Filters